Plus   Neg

Unilever To Resume Advertising On Facebook, Instagram, Twitter In U.S.

Consumer goods giant Unilever plc. (UN,ULVR.L,UL) announced Thursday its decision to resume brand advertising on social media newsfeed platforms Facebook, Instagram, and Twitter in the U.S. starting in January.

It was in June this year that company had paused advertising on these social media platforms through at least the end of 2020, in line with the principles of its Responsibility Framework.

The company aimed to create a diverse partner network that promotes a positive digital advertising ecosystem for consumers, brands, and society.

Unilever said it continued to work with the platforms to drive whole system change in the digital ecosystem. There are now some encouraging progress as part of the company's work with the Global Alliance for Responsible Media or GARM and other industry forums working with these partners.

The company said, "Facebook, Instagram and Twitter have committed to concrete steps to further manage harmful content moving forward, including common definitions for 11 harmful content areas, consistent reporting of prevalence of this content on these platforms, independent auditing, and developing controls for managing advertiser adjacency per the GARM commitments."

Unilever will closely assess the platforms' deliverables against their timelines and commitments, as well as polarization in the social media newsfeed environment post-election as the year progresses.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization. Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO) announced Tuesday the launch of its Cannabidiol (CBD) beverage brand Quatreau in the high-potential U.S. market. Quatreau will be sold on Canopy's one-stop U.S. e-commerce destination, www.shopcanopy.com. Quatreau is a premium ready-to-drink...
Follow RTT